We are live on
!
Find out more
Humacyte
HUMA
HUMA
158 hedge funds and large institutions have $35.9M invested in Humacyte in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
206% more call options, than puts
Call options by funds: $1.21M | Put options by funds: $397K
86% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 29
79% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 19
7% more funds holding
Funds holding: 147 → 158 (+11)
1.98% more ownership
Funds ownership: 29.54% → 31.51% (+2%)
32% less capital invested
Capital invested by funds: $53.1M → $35.9M (-$17.3M)
Holders
158
Holders Change
+11
Holders Change %
+7.48%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
54
Reduced
29
Closed
19
Calls
$1.21M
Puts
$397K
Net Calls
+$817K
Net Calls Change
-$134K
Top Buyers
| 1 |
AP
Antipodes Partners
Royal Exchange,
Australia
|
+$5.94M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.9M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.97M |
| 4 |
BlackRock
New York
|
+$1.01M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$282K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$2.62M |
| 2 |
Morgan Stanley
New York
|
-$2.41M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.63M |
| 4 |
Two Sigma Investments
New York
|
-$1.37M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.1M |